Wednesday, July 3, 2013
Durham’s Bioventus Gets Deal with Pfizer
Durham-based Bioventus has nabbed a big pharma platform for its orthopaedic healing portfolio: Pfizer’s bone morphogenetic protein.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment